United Kingdom: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Tyruko And Tysabri: Biosimilars And Their Differences
An investigation is underway after multiple sclerosis patients in the UK reported adverse effects following a switch from the originator medicine Tysabri to its biosimilar Tyruko. Despite regulatory approval confirming no clinically meaningful differences between the two natalizumab-based treatments, subtle variations in manufacturing processes, formulation buffers, and molecular characteristics may explain why some patients have experienced worsening symptoms or side effects.
United Kingdom Healthcare
B
Boult Wade Tennant
Article
Hidden Harm Facing Deaf Children: NHS Audiology Failures
Investigations into NHS paediatric audiology services have revealed systemic failures affecting hundreds of children, including delayed assessments and missed hearing loss diagnoses that may have impacted speech, language and educational development. Families affected by these failures in care may have legal options to pursue compensation where delays caused avoidable harm and lost opportunities for early intervention. Understanding the scope of these failures and the potential consequences for children's d
United Kingdom Healthcare
Bond Turner
See more
Article
Life Sciences Patents Monthly Roundup—July 2026
This monthly roundup examines critical patent law developments across multiple jurisdictions, including landmark UPC Court of Appeal decisions on preliminary injunctions and urgency requirements, French and Belgian court rulings on supplementary protection certificates and biosimilar equivalence, and UK guidance on expedition applications in pharmaceutical patent disputes. The analysis explores how courts are interpreting infringement standards, evidence production alignment in parallel proceedings, and the
Worldwide IP
AO
A&O Shearman
See more
Article
Life Sciences Patents Monthly Roundup—July 2026
This monthly roundup examines critical patent law developments across multiple jurisdictions, including landmark UPC Court of Appeal decisions on preliminary injunctions and urgency requirements, French and Belgian court rulings on supplementary protection certificates and biosimilar equivalence, and UK guidance on expedition applications in pharmaceutical patent disputes. The analysis explores how courts are interpreting infringement standards, evidence production alignment in parallel proceedings, and the
Worldwide IP
AO
A&O Shearman
See more
See more